Methamphetamine - Treatment for Habitual Users
Treatment for Habitual Users
Methamphetamine users experience extreme psychological withdrawal when they stop using the drug. People suffering from psychological withdrawal feel that they need to keep taking the drug because they can't function without it. Sommerfeld quoted drug researcher Douglas Anglin of the University of California at Los Angeles as saying, "There's not severe physical withdrawal with methamphetamine, but rather a feeling of anhedoniaPronounced ann-heh-DOE-nee-uh; the inability to experience pleasure from normally enjoyable life events. … that can last for months and which leads to a lot of relapse at six months." Withdrawal from methamphetamine is characterized by drug cravings, depression, an inability to sleep, and an increased appetite. Users in this stage may become suicidal.
Rehab: Difficult but Possible
Methamphetamine addicts often resist any form of treatment or intervention, according to Luna. They feel that they'll be able to quit on their own when they're ready. Among addicts who do seek help, the treatment process is typically lengthy. It can continue for months or even more than a year after the user has quit the drug. Antidepressant medications may be used to help battle the depression that can accompany withdrawal.
However, drug therapy usually is most helpful when combined with cognitive behavioral therapy (CBT)A type of therapy that helps people recognize and change negative patterns of thinking and behavior.. According to the Drug-Rehabs.org Web site, the most effective treatment for methamphetamine addiction consists of behavioral interventions such as individual and group counseling. These treatments help addicts establish a new circle of non-using friends and improve their coping skills to deal with everyday stressors.
NIDA Fights Against Meth Abuse
NIDA is pursuing research on drugs that could help with the treatment of methamphetamine addiction. Dr. Nora D. Volkow, the head of NIDA, appeared before the U.S. Senate to talk about methamphetamine abuse in 2005. She stated: "To further speed medication development efforts, NIDA has … established the Methamphetamine Clinical Trials Group (MCTG) to conduct clinical (human) trials of medications for [methamphetamine addiction] in geographic areas in which … abuse is particularly high, including San Diego, Kansas City, Des Moines, Costa Mesa, San Antonio, Los Angeles, and Honolulu." Among the drugs being tested are medicines used to treat high blood pressure, an anti-nausea drug, several antidepressants, and an anti-epilepsy drug. (Epilepsy is a disorder involving the misfiring of electrical impulses in the brain, sometimes resulting in seizures and loss of consciousness.) In addition, NIDA is funding research on a substance to treat meth overdoses.
